Achieving Sustainable Growth and Business Development through the Current M&A Environment, Creative Deal Structures and in Examining Organic Vs Inorganic Growth
(Atlanta, GA) – As the medical device industry changes, companies are looking to achieve sustainable growth. Business development and corporate strategy executives are deemed the task of finding the next new endeavor that will help propel their organization forward. Whether an organization’s next focused endeavor is organic or inorganic, it is the role of the business development executive to determine which decision will bring optimal return on investment for their organization.
The Medical Device Business Development conference, hosted by Q1 Productions, will be held January 30-31, 2015 in Atlanta, GA, and will offer perspectives from all corners of the medical device industry. Some of the industry’s most experienced professionals will be leading sessions, case studies and panel discussions, including Indraneel Kanaglekar of Zimmer Biomet, Nicholas Pachuda of Johnson & Johnson and Chris Lyons of Medtronic. Topics addressed include insights into the current state of the Medical Device Industry and its impact on the M&A landscape, in-depth discussions of balancing organic vs. inorganic growth, and case studies and examination of creative deal structures.
The conference, featuring more than 24 presenters, will meld perspectives of industry veterans; from academic to small, medium and large companies, along with multiple networking opportunities that will take place throughout the course of the two-day meeting.
For more information on the Medical Device Corporate Strategy and Business Development Conference, or any of Q1 Productions’ upcoming conferences, please visit www.q1productions.com/business-development. You can also follow Q1 Productions on Twitter,@Q1Productions, #BizDev16.
